| 摘要 |
The present invention relates to thiazolidinedione derivatives of omega- 3 fatty acids as insulin sensitizers, and their use in treating Type2 diabetes, obesity, hypertriglyceridemia, cardiovascular diseases, metabolic diseases, inflammation, renal anemia, and/or Alzheimer's disease: and for modulating activity of peroxisome proliferator- activated receptors (PPARs). |
